Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J D Bower

Showing results (81-90 of 87) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 87 results.
Nephrology News & Issues|June 26, 1999
The RPA. Celebrating 25 years as an advocate for nephrologyA R Nissenson, J H Sadler, C R Blagg, et al.
Translational Psychiatry|September 21, 2016
Characterizing cognitive control abilities in children with 16p11.2 deletion using adaptive 'video game' technology: a pilot studyJ A Anguera, A N Brandes-Aitken, C E Rolle, et al.
Artificial Organs|February 1, 1978
Evaluation of hemodialyzers and dialysis membranes. Report of a study for the artificial kidney-chronic uremia program NIAMDD-1977E Klein, J Autian, J D Bower, et al.
Artificial Organs|August 1, 1978
Evaluation of hemodialyzers and dialysis membranes. Report of a study group for the Artificial Kidney-Chronic Uremia Program NIAMDD-1977. Chapter five. Evaluation of toxicity potential of hemodialyzersE Klein, J Autian, J D Bower, et al.
Artificial Organs|February 1, 1979
Chapter six: clinical evaluation. Evaluation of hemodialyzers and dialysis membranes. Report of a study group for the Artificial Kidney-Chronic Uremia Program NIAMMDD-1977E Klein, J Autian, J D Bower, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 8, 2000
Intermittent doxercalciferol (1alpha-hydroxyvitamin D(2)) therapy for secondary hyperparathyroidismJ M Frazão, L Elangovan, H M Maung, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 3, 2001
Efficacy and side effects of intermittent intravenous and oral doxercalciferol (1alpha-hydroxyvitamin D(2)) in dialysis patients with secondary hyperparathyroidism: a sequential comparisonH M Maung, L Elangovan, J M Frazão, et al.
Pageof 9

Showing results (81-90 of 87) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 87 results.
Nephrology News & Issues|June 26, 1999
The RPA. Celebrating 25 years as an advocate for nephrologyA R Nissenson, J H Sadler, C R Blagg, et al.
Translational Psychiatry|September 21, 2016
Characterizing cognitive control abilities in children with 16p11.2 deletion using adaptive 'video game' technology: a pilot studyJ A Anguera, A N Brandes-Aitken, C E Rolle, et al.
Artificial Organs|February 1, 1978
Evaluation of hemodialyzers and dialysis membranes. Report of a study for the artificial kidney-chronic uremia program NIAMDD-1977E Klein, J Autian, J D Bower, et al.
Artificial Organs|August 1, 1978
Evaluation of hemodialyzers and dialysis membranes. Report of a study group for the Artificial Kidney-Chronic Uremia Program NIAMDD-1977. Chapter five. Evaluation of toxicity potential of hemodialyzersE Klein, J Autian, J D Bower, et al.
Artificial Organs|February 1, 1979
Chapter six: clinical evaluation. Evaluation of hemodialyzers and dialysis membranes. Report of a study group for the Artificial Kidney-Chronic Uremia Program NIAMMDD-1977E Klein, J Autian, J D Bower, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 8, 2000
Intermittent doxercalciferol (1alpha-hydroxyvitamin D(2)) therapy for secondary hyperparathyroidismJ M Frazão, L Elangovan, H M Maung, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 3, 2001
Efficacy and side effects of intermittent intravenous and oral doxercalciferol (1alpha-hydroxyvitamin D(2)) in dialysis patients with secondary hyperparathyroidism: a sequential comparisonH M Maung, L Elangovan, J M Frazão, et al.
Pageof 9